133 related articles for article (PubMed ID: 35130925)
1. Dual CRISPR interference and activation for targeted reactivation of X-linked endogenous FOXP3 in human breast cancer cells.
Cui X; Zhang C; Xu Z; Wang S; Li X; Stringer-Reasor E; Bae S; Zeng L; Zhao D; Liu R; Qi LS; Wang L
Mol Cancer; 2022 Feb; 21(1):38. PubMed ID: 35130925
[TBL] [Abstract][Full Text] [Related]
2. Targeted Modulation of Chicken Genes In Vitro Using CRISPRa and CRISPRi Toolkit.
Chapman B; Han JH; Lee HJ; Ruud I; Kim TH
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107664
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
Umeh-Garcia M; O'Geen H; Simion C; Gephart MH; Segal DJ; Sweeney CA
Br J Cancer; 2022 Aug; 127(3):436-448. PubMed ID: 35440669
[TBL] [Abstract][Full Text] [Related]
5. FOXP3 as an X-linked tumor suppressor.
Wang L; Liu R; Ribick M; Zheng P; Liu Y
Discov Med; 2010 Oct; 10(53):322-8. PubMed ID: 21034673
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter.
Choudhury SR; Cui Y; Lubecka K; Stefanska B; Irudayaraj J
Oncotarget; 2016 Jul; 7(29):46545-46556. PubMed ID: 27356740
[TBL] [Abstract][Full Text] [Related]
7. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.
Sirchia SM; Ramoscelli L; Grati FR; Barbera F; Coradini D; Rossella F; Porta G; Lesma E; Ruggeri A; Radice P; Simoni G; Miozzo M
Cancer Res; 2005 Mar; 65(6):2139-46. PubMed ID: 15781624
[TBL] [Abstract][Full Text] [Related]
8. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.
Zuo T; Wang L; Morrison C; Chang X; Zhang H; Li W; Liu Y; Wang Y; Liu X; Chan MW; Liu JQ; Love R; Liu CG; Godfrey V; Shen R; Huang TH; Yang T; Park BK; Wang CY; Zheng P; Liu Y
Cell; 2007 Jun; 129(7):1275-86. PubMed ID: 17570480
[TBL] [Abstract][Full Text] [Related]
9. Artificial escape from XCI by DNA methylation editing of the CDKL5 gene.
Halmai JANM; Deng P; Gonzalez CE; Coggins NB; Cameron D; Carter JL; Buchanan FKB; Waldo JJ; Lock SR; Anderson JD; O'Geen H; Segal DJ; Nolta J; Fink KD
Nucleic Acids Res; 2020 Mar; 48(5):2372-2387. PubMed ID: 31925439
[TBL] [Abstract][Full Text] [Related]
10. A CRISPRi-dCas9 System for Archaea and Its Use To Examine Gene Function during Nitrogen Fixation by Methanosarcina acetivorans.
Dhamad AE; Lessner DJ
Appl Environ Microbiol; 2020 Oct; 86(21):. PubMed ID: 32826220
[TBL] [Abstract][Full Text] [Related]
11. Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture.
Geens M; Seriola A; Barbé L; Santalo J; Veiga A; Dée K; Van Haute L; Sermon K; Spits C
Mol Hum Reprod; 2016 Apr; 22(4):285-98. PubMed ID: 26786180
[TBL] [Abstract][Full Text] [Related]
12. FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1.
Katoh H; Qin ZS; Liu R; Wang L; Li W; Li X; Wu L; Du Z; Lyons R; Liu CG; Liu X; Dou Y; Zheng P; Liu Y
Mol Cell; 2011 Dec; 44(5):770-84. PubMed ID: 22152480
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer.
Tejedor JR; Peñarroya A; Gancedo-Verdejo J; Santamarina-Ojeda P; Pérez RF; López-Tamargo S; Díez-Borge A; Alba-Linares JJ; González-Del-Rey N; Urdinguio RG; Mangas C; Roberti A; López V; Morales-Ruiz T; Ariza RR; Roldán-Arjona T; Meijón M; Valledor L; Cañal MJ; Fernández-Martínez D; Fernández-Hevia M; Jiménez-Fonseca P; García-Flórez LJ; Fernández AF; Fraga MF
Clin Epigenetics; 2023 Aug; 15(1):133. PubMed ID: 37612734
[TBL] [Abstract][Full Text] [Related]
14. Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer.
Waryah C; Cursons J; Foroutan M; Pflueger C; Wang E; Molania R; Woodward E; Sorolla A; Wallis C; Moses C; Glas I; Magalhães L; Thompson EW; Fearnley LG; Chaffer CL; Davis M; Papenfuss AT; Redfern A; Lister R; Esteller M; Blancafort P
Adv Sci (Weinh); 2023 Aug; 10(22):e2301802. PubMed ID: 37217832
[TBL] [Abstract][Full Text] [Related]
15. High-resolution RNA allelotyping along the inactive X chromosome: evidence of RNA polymerase III in regulating chromatin configuration.
Hong R; Lin B; Lu X; Lai LT; Chen X; Sanyal A; Ng HH; Zhang K; Zhang LF
Sci Rep; 2017 Apr; 7():45460. PubMed ID: 28368037
[TBL] [Abstract][Full Text] [Related]
16. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
[TBL] [Abstract][Full Text] [Related]
17. Regulation of X-chromosome inactivation in development in mice and humans.
Goto T; Monk M
Microbiol Mol Biol Rev; 1998 Jun; 62(2):362-78. PubMed ID: 9618446
[TBL] [Abstract][Full Text] [Related]
18. Evidence of Xist RNA-independent initiation of mouse imprinted X-chromosome inactivation.
Kalantry S; Purushothaman S; Bowen RB; Starmer J; Magnuson T
Nature; 2009 Jul; 460(7255):647-51. PubMed ID: 19571810
[TBL] [Abstract][Full Text] [Related]
19. Quantitative and modularized CRISPR/dCas9-dCpf1 dual function system in
Feng Q; Ning X; Qin L; Li J; Li C
Front Bioeng Biotechnol; 2023; 11():1218832. PubMed ID: 38026848
[No Abstract] [Full Text] [Related]
20. CRISPRa-mediated
Forstnerič V; Oven I; Ogorevc J; Lainšček D; Praznik A; Lebar T; Jerala R; Horvat S
Cell Biosci; 2019; 9():93. PubMed ID: 31832140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
